$109 Million is the total value of ACCIPITER CAPITAL MANAGEMENT, LLC's 9 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 37.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GTS | Buy | TRIPLE - S MGMT CORPcl b | $42,103,000 | -10.1% | 2,289,460 | +5.0% | 38.68% | +5.2% |
| TEVA | Buy | TEVA PHARMACEUTICALS INDS LTDadr | $16,554,000 | +16.4% | 438,172 | +20.8% | 15.21% | +36.2% |
| V107SC | Sell | WELLPOINT INC | $11,599,000 | -33.8% | 138,728 | -35.2% | 10.66% | -22.6% |
| ESRX | Sell | EXPRESS SCRIPTS INC COM | $10,792,000 | +0.0% | 174,621 | -0.1% | 9.91% | +17.0% |
| AET | Sell | AETNA INC NEW | $10,722,000 | -34.4% | 167,482 | -34.9% | 9.85% | -23.2% |
| HPQ | Buy | HEWLETT-PACKARD COMPANY | $10,495,000 | +20.9% | 500,000 | +42.9% | 9.64% | +41.5% |
| KND | New | KINDRED HEALTHCARE INC | $4,907,000 | – | 365,351 | +100.0% | 4.51% | – |
| MNKD | Buy | MANNKIND | $855,000 | +31.3% | 150,000 | +50.0% | 0.78% | +53.6% |
| OSIR | New | OSIRIS THERAPEUTICS INC | $832,000 | – | 50,000 | +100.0% | 0.76% | – |
| CI | Exit | CIGNA CORPORATION | $0 | – | -170,127 | -100.0% | -9.68% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARM ADR | 17 | Q2 2018 | 21.9% |
| FORESIGHT ENERGY LP | 13 | Q3 2018 | 81.7% |
| SHIRE PLC | 9 | Q1 2018 | 25.3% |
| HEWLETT-PACKARD COMPANY | 7 | Q4 2015 | 17.8% |
| TRIPLE - S MGMT CORP | 5 | Q2 2014 | 49.4% |
| VALEANT PHARMACEUTICALS INTL | 5 | Q4 2016 | 39.1% |
| COMMUNITY HEALTH SYSTEMS | 5 | Q4 2016 | 25.7% |
| KINDRED HEALTHCARE INC | 5 | Q3 2014 | 13.3% |
| PERRIGO CO PLC | 4 | Q4 2016 | 15.2% |
| BIOGEN IDEC INC COM | 4 | Q1 2016 | 12.5% |
View ACCIPITER CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Foresight Energy LPSold out | February 14, 2020 | 0 | 0.0% |
| TRIPLE-S MANAGEMENT CORP | April 28, 2014 | 118,172 | 4.3% |
| ORCHID CELLMARK INC | May 06, 2011 | 1,581,113 | 5.3% |
| NightHawk Radiology Holdings IncSold out | February 16, 2010 | 0 | 0.0% |
| YM BIOSCIENCES INCSold out | February 16, 2010 | 0 | 0.0% |
| RURAL/METRO CORP /DE/ | January 06, 2010 | 461,351 | 1.8% |
| IMPAX LABORATORIES INC | June 30, 2009 | 140,385 | 0.2% |
| ATHERSYS, INC / NEW | February 17, 2009 | 365,132 | 1.9% |
| ATS MEDICAL INC | February 17, 2009 | 1,161,557 | 1.6% |
| EMAGEON INC | February 17, 2009 | 1,098,984 | 5.1% |
View ACCIPITER CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2020-02-14 |
| SC 13G/A | 2019-02-14 |
| 13F-HR | 2018-11-14 |
| 13F-HR | 2018-08-14 |
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| SC 13G/A | 2018-02-14 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
View ACCIPITER CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.